Eraphar SRL
The score of Eraphar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +132 % Total assets +64 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Eraphar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Aug 2026
- Year ended 31 Dec 2024filed on 19 Aug 2025
- Year ended 31 Dec 2023filed on 13 Aug 2024
Eraphar's financial analysis
- Solvency78.1%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Eraphar
Eraphar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0785.516.292
- VAT number
- BE0785516292
- Peppol
- Registered · 0208:0785516292 · as of 08 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Apr 2022
- Registered office
- 9450 Haaltert
- Latest accounts
- 2025 · filed on 25 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Eraphar (SRL) has been based in Haaltert since 2022, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 12,094 € and equity of 39,157 €; its revenue is not published. Its solvency stands at 78.1%, above the median of its sector (44.2%).
Companies similar to Eraphar
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Pharmiste Retail sale of pharmaceutical products Brussels · balance sheet 57,475 €
- Astrid Fivez Retail sale of pharmaceutical products Destelbergen · balance sheet 52,168 €
- Apotheker Jorn Christiaens Retail sale of pharmaceutical products Lennik · balance sheet 47,763 €
- Bephacon Retail sale of pharmaceutical products Beveren-Kruibeke-Zwijndrecht · balance sheet 52,631 €
- Elisabeth in ’t Veld Retail sale of pharmaceutical products Holsbeek · balance sheet 46,905 €
- Sevens Elise Retail sale of pharmaceutical products Wetteren · balance sheet 53,817 €
- Apotheek A. Janssens Retail sale of pharmaceutical products Maasmechelen · balance sheet 55,793 €
- Pharmaes Retail sale of pharmaceutical products Anderlecht · balance sheet 57,673 €
Frequently asked questions about Eraphar
What is the revenue of Eraphar?
Eraphar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Eraphar?
In Belgium, the VAT number is the company number prefixed with BE: BE0785516292 for Eraphar, if the company is VAT-registered. Its company number (CBE) is 0785.516.292.
Where is the registered office of Eraphar?
According to the CBE register, the registered office of Eraphar is in 9450 Haaltert.
What is the equity of Eraphar?
At the close of the 2025 financial year, the equity of Eraphar amounts to 39,157 €, a solvency of 78.1% of total assets.
Who manages Eraphar?
The register lists 1 active mandates at Eraphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Eraphar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →